Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Increased hepatic glucose production with lower oxidative metabolism in the growth-restricted fetus
Laura D. Brown, Paul J. Rozance, Dong Wang, Evren C. Eroglu, Randall B. Wilkening, Ashley Solmonson, Stephanie R. Wesolowski
Laura D. Brown, Paul J. Rozance, Dong Wang, Evren C. Eroglu, Randall B. Wilkening, Ashley Solmonson, Stephanie R. Wesolowski
View: Text | PDF
Research Article Reproductive biology

Increased hepatic glucose production with lower oxidative metabolism in the growth-restricted fetus

  • Text
  • PDF
Abstract

Fetal growth restriction (FGR) is accompanied by early activation of hepatic glucose production (HGP), a hallmark of type 2 diabetes (T2D). Here, we used fetal hepatic catheterization to directly measure HGP and substrate flux in a sheep FGR model. We hypothesized that FGR fetuses would have increased hepatic lactate and amino acid uptake to support increased HGP. Indeed, FGR fetuses compared with normal (CON) fetuses had increased HGP and activation of gluconeogenic genes. Unexpectedly, hepatic pyruvate output was increased, while hepatic lactate and gluconeogenic amino acid uptake rates were decreased in FGR liver. Hepatic oxygen consumption and total substrate uptake rates were lower. In FGR liver tissue, metabolite abundance, 13C-metabolite labeling, enzymatic activity, and gene expression supported decreased pyruvate oxidation and increased lactate production. Isolated hepatocytes from FGR fetuses had greater intrinsic capacity for lactate-fueled glucose production. FGR livers also had lower energy (ATP) and redox state (NADH/NAD+ ratio). Thus, reduced hepatic oxidative metabolism may make carbons available for increased HGP, but also produces nutrient and energetic stress in FGR liver. Intrinsic programming of these pathways regulating HGP in the FGR fetus may underlie increased HGP and T2D risk postnatally.

Authors

Laura D. Brown, Paul J. Rozance, Dong Wang, Evren C. Eroglu, Randall B. Wilkening, Ashley Solmonson, Stephanie R. Wesolowski

×

Figure 1

Decreased hepatic blood flow and increased hepatic glucose production in FGR fetuses.

Options: View larger image (or click on image) Download as PowerPoint
Decreased hepatic blood flow and increased hepatic glucose production in...
(A) Fetal weight in CON and FGR groups. Dashed line at 2 kg indicates the separation between moderate (light pink) and severe (dark red) FGR. (B) Fetal left and right lobe liver weights. (C) Left hepatic catheterization method showing input (hin) and output (hout) across the left lobe. (D) Percentage contribution of umbilical vein and fetal artery blood supply to the left lobe. (E) Fetal hepatic blood flow normalized per 100 g of liver weight. (F) Net hepatic glucose uptake. (G) Hepatic glucose utilization. (H) Total hepatic glucose production (sum of utilization and net uptake). (I) Glucose tracer enrichment (m+6 MPE) ratio across the fetal liver. (J) Expression of gluconeogenic genes in liver tissue. (K) Hepatic tissue glycogen content. Means ± SEM are shown (n = 5–6 CON, 10 FGR in panels A–I and n = 13 CON, 21 FGR in panels J and K). Results comparing CON (white bar) versus FGR (gray bar) groups were analyzed by 2-tailed Student’s t test, except panel I, where a Welch’s t test was used. In panels H and I, a 1-sample Wilcoxon test was used to test whether each group was greater than zero (panel H) or less than 1.0 (panel I) and differences are indicated with a double dagger. Weight-threshold differences comparing moderate versus severe FGR were analyzed by 2-tailed Student’s t test and are indicated by a vertical line. ‡P < 0.05; *P < 0.05; **P < 0.01, ***P < 0.001.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts